Formulation and evaluation of macrophage targeted amphotericin b and miltefosine combination nanovesicles for the treatment of visceral leishmaniasis

Abstract

None

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced